dilazep has been researched along with Chronic Kidney Failure in 2 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakamura, T | 1 |
| Hirokawa, K | 1 |
| Matsuda, T | 1 |
| Osada, S | 1 |
| Takahashi, Y | 1 |
| Shimada, N | 1 |
| Koide, H | 1 |
| Saito, H | 1 |
| Saito, A | 1 |
| Ogawa, H | 1 |
2 other studies available for dilazep and Chronic Kidney Failure
| Article | Year |
|---|---|
Combination AST-120 and dilazep dihydrochloride therapy reduced urinary protein excretion and serum creatinine levels in patients with chronic renal failure.
Topics: Aged; Carbon; Creatinine; Dilazep; Drug Therapy, Combination; Female; Humans; Kidney Failure, Chroni | 2002 |
[The effect of dilazep on red cell survival].
Topics: Aged; Azepines; Dilazep; Erythrocyte Aging; Female; Humans; Kidney Failure, Chronic; Male; Middle Ag | 1985 |